4//SEC Filing
Kender Richard N 4
Accession 0000899243-22-024013
CIK 0001609809other
Filed
Jun 23, 8:00 PM ET
Accepted
Jun 24, 4:36 PM ET
Size
5.4 KB
Accession
0000899243-22-024013
Insider Transaction Report
Form 4
Kender Richard N
Director
Transactions
- Award
Stock Option (right to buy)
2022-06-22+35,000→ 35,000 totalExercise: $3.22Exp: 2032-06-21→ Common Stock (35,000 underlying)
Footnotes (1)
- [F1]The option vests in full on the earlier of June 22, 2023 or the day immediately prior to the company's 2023 annual meeting of shareholders.
Documents
Issuer
Seres Therapeutics, Inc.
CIK 0001609809
Entity typeother
Related Parties
1- filerCIK 0001381205
Filing Metadata
- Form type
- 4
- Filed
- Jun 23, 8:00 PM ET
- Accepted
- Jun 24, 4:36 PM ET
- Size
- 5.4 KB